Suivre
Sarah GJA Peeters
Sarah GJA Peeters
Adresse e-mail validée de oncology.ox.ac.uk
Titre
Citée par
Citée par
Année
Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation
L Dubois, S Peeters, NG Lieuwes, N Geusens, A Thiry, S Wigfield, F Carta, ...
Radiotherapy and Oncology 99 (3), 424-431, 2011
2112011
A comparative study of the hypoxia PET tracers [18F] HX4,[18F] FAZA, and [18F] FMISO in a preclinical tumor model
SGJA Peeters, CML Zegers, NG Lieuwes, W van Elmpt, J Eriksson, ...
International Journal of Radiation Oncology* Biology* Physics 91 (2), 351-359, 2015
1942015
TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging
SGJA Peeters, CML Zegers, R Biemans, NG Lieuwes, ...
Clinical cancer research 21 (13), 2984-2992, 2015
1192015
Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs
L Dubois, SGJA Peeters, SJA van Kuijk, A Yaromina, NG Lieuwes, ...
Radiotherapy and Oncology 108 (3), 523-528, 2013
952013
New ways to image and target tumour hypoxia and its molecular responses
LJ Dubois, R Niemans, SJA van Kuijk, KM Panth, NK Parvathaneni, ...
Radiotherapy and Oncology 116 (3), 352-357, 2015
612015
Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles
SG Peeters, CM Zegers, A Yaromina, W Van Elmpt, L Dubois, P Lambin
QJ Nucl Med Mol Imaging 59 (1), 39-57, 2015
572015
Preclinical assessment of efficacy of radiation dose painting based on intratumoral FDG-PET uptake
D Trani, A Yaromina, L Dubois, M Granzier, SGJA Peeters, R Biemans, ...
Clinical Cancer Research 21 (24), 5511-5518, 2015
382015
[18F]VM4-037 MicroPET Imaging and Biodistribution of Two In Vivo CAIX-Expressing Tumor Models
SGJA Peeters, L Dubois, NG Lieuwes, D Laan, M Mooijer, RC Schuit, ...
Molecular imaging and biology 17, 615-619, 2015
382015
A phase 1 ‘window-of-opportunity’trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal …
RTHM Larue, L Van De Voorde, M Berbée, WJC van Elmpt, LJ Dubois, ...
BMC cancer 16 (1), 1-8, 2016
302016
Dosimetric evaluation of radionuclides for VCAM-1-targeted radionuclide therapy of early brain metastases
N Falzone, NL Ackerman, L de la Fuente Rosales, MA Bernal, X Liu, ...
Theranostics 8 (1), 292, 2018
202018
Microbubbles Containing Lysolipid Enhance Ultrasound‐Mediated Blood–Brain Barrier Breakdown In Vivo
O Vince, S Peeters, VA Johanssen, M Gray, S Smart, NR Sibson, E Stride
Advanced Healthcare Materials 10 (3), 2001343, 2021
92021
(In) organic anions as carbonic anhydrase inhibitors
N Krall, F Pretto, W Decurtins, SU Rehman, ZH Chohan, F Gulnaz, ...
Angew Chem Int Ed Engl 53, 4231-5, 2014
72014
Inhibition of the archaeal β-class (Cab) and γ-class (Cam) carbonic anhydrases
N Krall, F Pretto, W Decurtins, SU Rehman, ZH Chohan, F Gulnaz, ...
Angew Chem Int Ed Engl 53, 4231-5, 2014
52014
Synthesis and Radiosynthesis of Prospective 2-Nitroimidazole Hypoxia PET Tracers via Thiazolidine Ligation with 5-Fluorodeoxyribose (FDR)
M Musolino, S Dall’Angelo, M Zanda
SynOpen 1 (01), 0173-0179, 2017
22017
PV-0039: Outcome of elderly NSCLC patients treated with isotoxic RT dose-escalation using IMRT (NCT01166204)
J Van Loon, D De Ruysscher, S Peeters, K Verhoeven, G Bootsma, ...
Radiotherapy and Oncology 127, S15-S16, 2018
12018
Abstract B144: Hypoxia imaging with [18F] HX4 PET compared with [18F] FMISO and [18F] FAZA: From preclinical to clinical studies.
S Peeters, C Zegers, N Lieuwes, W van Elmpt, F Hoebers, H Sharifi, ...
Molecular Cancer Therapeutics 12 (11_Supplement), B144-B144, 2013
12013
PO-1024: Fractionated RT is equally effective but less toxic than SBRT for central early-stage NSCLC
M Leenders, S Peeters, J Van Loon, A Van Baardwijk, B Reymen, ...
Radiotherapy and Oncology 152, S546, 2020
2020
PO-1573: First clinical experience with model-based selection for breast cancer proton therapy
K Verhoeven, G Vilches-Freixas, K Limpens, J Mannens, K Van der Klugt, ...
Radiotherapy and Oncology 152, S852-S853, 2020
2020
Prospectively registered acute toxicity in breast cancer patients undergoing adjuvant intensity modulated proton therapy
K Verhoeven, T Opbroek, G Vilches-Freixas, K Limpens, J Mannens, ...
European Journal of Cancer 138, S85, 2020
2020
Antibody targeted ultrasound-responsive nanodroplets for the therapy of brain metastases: A pre-clinical study
O Vince, L Bau, S Peeters, M Gray, L Richards, S Smart, N Sibson, ...
The Journal of the Acoustical Society of America 144 (3), 1852-1852, 2018
2018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20